Yaniv D, et al. - Researchers sought to assess the safety and effectiveness of the composite sinus stent used to stabilize the middle turbinate and prevent adhesions following endoscopic sinus surgery (ESS). They performed a prospective clinical trial in a single medical center in 2016–2018 including 30 patients. Randomization of the patients scheduled for bilateral ESS to undergo composite sinus stent implantation for 14 to 28 days or middle meatus placement of a Telfa tampon for 2 to 3 days was performed. Outcomes support the higher safety and efficacy of composite sinus stent vs Telfa tampon in maintaining sinus cavity patency and promoting healing following ESS.